EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease

Juliana Bernardi Aggio, Verônica Vitória Vedam, Líndice Mitie Nisimura, Rosiane Valeriano da Silva, Maria Izabel Lovo-Martins, Beatriz Santana Borges, Patrícia Alves Mörking, Michel Batista, Fabricio Klerynton Marchini, Sueli Fumie Yamada-Ogatta iD, Phileno Pinge-Filho iD, Samuel Goldenberg iD und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Juliana Bernardi Aggio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil. Hauptthemen laut MEDLINE: Extracellular Vesicles, Chagas Disease, Trypanosoma cruzi, Antigens, Protozoan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Araucária, CNPq-Universal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas disease remains a significant public health concern, with limited treatment options and an urgent need for novel preventive strategies. Extracellular vesicles (EVs) from Trypanosoma cruzi have been shown to modulate host immune responses, often favoring parasite persistence. In this study, we characterized EVs derived from the non-pathogenic trypanosomatids Trypanosoma rangeli and Phytomonas serpens and evaluated their potential as immunogens capable of inducing cross-protection against T. cruzi infection. Isolated EVs were characterized by Nanoparticle Tracking Analysis (NTA) and electron microscopy. A comparative proteomic analysis of EVs was performed using Mass Spectrometry-Based Proteomic Analysis (LC-MS/MS). The effects of EVs on immunomodulation and T. cruzi infection were assessed through in vitro and in vivo assays, using peripheral blood mononuclear cells (PBMCs) and BALB/c mice. The proteomic analysis identified shared proteins between the EVs of T. rangeli, P. serpens, and T. cruzi, including immunogenic candidates such as calpain-like cysteine peptidase and elongation factor 2. In vitro, pre-stimulation with the T. rangeli EVs reduced infection rates of the host cells by T. cruzi. In vivo, immunization with the EVs from T. rangeli and P. serpens led to a significant reduction in parasitemia in the BALB/c mice challenged with T. cruzi, though this did not translate into improved survival compared to controls. Interestingly, the EVs from T. cruzi also reduced parasitemia but did not confer protection against mortality. These findings suggest that while non-pathogenic trypanosomatid EVs exhibit potential immunogenic properties and can reduce parasitic load, their efficacy in preventing disease progression remains limited. Further research is needed to explore the mechanisms underlying these effects and to optimize EV-based strategies for protective immunity against Chagas disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesChagas DiseaseTrypanosoma cruziAntigens, ProtozoanProtozoan VaccinesTrypanosomatinaAnimalsMiceMice, Inbred BALB CProteomicsProtozoan ProteinsLeukocytes, MononuclearFemaleHumansTrypanosoma rangeli

Stichwörter der Autor:innen

Chagas diseasePhytomonas serpensTrypanosoma cruziTrypanosoma rangelicross-protectionextracellular vesiclesimmunogenicityproteomic

Substanzen

Protozoan ProteinsAntigens, ProtozoanProtozoan Vaccines

Autor:innen und Institutionen

  • Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil.
  • Laboratório de Biologia Celular e Protozoologia, Universidade Estadual de Ponta Grossa, Ponta Grossa 84030-900, Brazil.
  • Grupo de Imunologia Molecular, Celular e Inteligência Artificial, Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil.
  • Laboratório de Imunopatologia Experimental, Departamento de Imunologia, Parasitologia e Patologia Geral, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.
  • Laboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina 86057-970, Brazil.

ORCID-Profile: Sueli Fumie Yamada-Ogatta, Phileno Pinge-Filho, Samuel Goldenberg, Iriane Eger, Pryscilla Fanini Wowk

Förderung

  • National Council for Scientific and Technological Development
  • Fundação Araucária
  • CNPq-Universal
  • Pesquisas sobre Doença de Chagas
  • Fundação Araucária, PRONEX
  • PROGRAMA PESQUISA BÁSICA E APLICADA

Zitieren

APA

Aggio, J. B., Vedam, V. V., Nisimura, L. M., da Silva, R. V., Lovo-Martins, M. I., Borges, B. S., Mörking, P. A., Batista, M., Marchini, F. K., Yamada-Ogatta, S. F., Pinge-Filho, P., Goldenberg, S., Eger, I., & Wowk, P. F. (2025). Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041544

Vancouver

Aggio JB, Vedam VV, Nisimura LM, da Silva RV, Lovo-Martins MI, Borges BS, et al. Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041544

BibTeX
@article{Aggio2025,
  author = {Aggio, Juliana Bernardi and Vedam, Verônica Vitória and Nisimura, Líndice Mitie and da Silva, Rosiane Valeriano and Lovo-Martins, Maria Izabel and Borges, Beatriz Santana and Mörking, Patrícia Alves and Batista, Michel and Marchini, Fabricio Klerynton and Yamada-Ogatta, Sueli Fumie and Pinge-Filho, Phileno and Goldenberg, Samuel and Eger, Iriane and Wowk, Pryscilla Fanini},
  title = {Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041544}
}
Kostenlos starten →